Doctor of Osteopathy Program year 2021 Reported 2019–2021 Source: CMS Open Payments, 2026 publication

John Vargo

Geriatric Medicine Austintown, OH Doctor of Osteopathy

NPI 1316930100 CMS profile 514251

5480 Norquest Blvd, Austintown, OH 44515

Open in the dashboard

General payments

$2,492

151 records reported · program years 2019–2021

Research payments

$0

Paid to them · None reported · program years 2019–2021

Ownership & investment interest

$0

None reported

Through program year 2021, John Vargo of Austintown, OH is reported in the CMS Open Payments database as having received $2,492 across 151 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 88th percentile of Geriatric Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2021 General $438 20
2020 General $1,366 88
2019 General $688 43

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Vargo
  • Geriatric Medicine median
  • Middle half of Geriatric Medicine
  • National median

In program year 2025, general payments to John Vargo were reported at $0. Among 512 Geriatric Medicine profiles paid that year, the median was $120 and the middle half received between $37 and $350.

Show as a table
Year John Vargo Geriatric Medicine median Middle half National median
2019 $688 $96 $28–$339 $163
2020 $1,366 $99 $28–$262 $114
2021 $438 $94 $27–$318 $132
2022 $0 $103 $34–$338 $149
2023 $0 $109 $39–$320 $160
2024 $0 $125 $36–$371 $164
2025 $0 $120 $37–$350 $169

Breakdown

Who paid General payments · program years 2019–2021
  1. Pfizer Inc. $473 39 payments
  2. Salix Pharmaceuticals, a division of Bausch Health US, LLC $218 14 payments
  3. Cook Medical LLC $209 2 payments
  4. Boehringer Ingelheim Pharmaceuticals, Inc. $204 13 payments
  5. Amarin Pharma Inc. $181 11 payments
  6. Teva Pharmaceuticals USA, Inc. $158 8 payments
  7. Merck Sharp & Dohme Corporation $115 8 payments
  8. GlaxoSmithKline, LLC. $92 6 payments
  9. Novo Nordisk Inc $85 6 payments
  10. Eisai Inc. $84 5 payments
  11. Other $672 39 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2021
  1. Food and Beverage $2,486 150 payments
  2. Education $6 1 payment
Products named General payments · program years 2019–2021
  1. COLOGUARD $333 24 payments
  2. SPIRIVA RESPIMAT $269 17 payments
  3. XIFAXAN $218 14 payments
  4. Vascepa $181 11 payments
  5. EUCRISA $178 13 payments
  6. AJOVY $140 7 payments
  7. CHANTIX $136 10 payments
  8. Cook Medical Biliary $116 1 payment
  9. JANUVIA $115 8 payments
  10. BELSOMRA $102 7 payments
  11. Other $1,770 117 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

151 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Geriatric Medicine in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2021

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record